to solve generation-defining problems at scale
Our platform connects large institutional investors to leading early stage companies. We deploy institutional capital to empower entrepreneurs to ‘scalebig’ through patient venture. Enabling them to focus on building products that will transform industries. We partner with smart seed investors to increase impact through collaborative capital.
We’re experienced tech entrepreneurs and operators. We’ve felt the pain caused by the gaps in venture capital which can restrict the growth of companies and the impact of investors. We’ve built some products designed to fill these gaps.
‘Scalebig’ companies can take 10 or 20 years to build. Traditional venture timeframes can’t always accommodate that. So we practice patient venture by bringing patient capital into early stage investing. It’s designed specifically to sustain companies with big ambitions over the long term. Here’s how we work with founders.
Early stage investors can be restricted by lack of capital. Our pro rata product means our fund partners can keep backing their most promising portfolio companies. They maintain their holding and the partnership with the company. We share the potential opportunity.
We operate a co-investment model with our fund partners. When they’re making a follow-on investment into portfolio company, the founder can fast track to our investment committee. Syndicates and rounds get built fast, allowing founders to focus on growing companies.
We make investments as an LP into selected early stage funds. The funds we invest in have a track record of finding exceptional founders and fuelling their scaleup journey.